Photocure ASA
OSE:PHO

Watchlist Manager
Photocure ASA Logo
Photocure ASA
OSE:PHO
Watchlist
Price: 58.7 NOK -0.51%
Market Cap: 1.6B NOK
Have any thoughts about
Photocure ASA?
Write Note

P/E
Price to Earnings

112.3
Current
-31.5
Median
21.4
Industry
Higher than median
Higher than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
112.3
=
Market Cap
1.6B NOK
/
Net Income
14.2m NOK
All Countries
Close
Market Cap P/E
NO
Photocure ASA
OSE:PHO
1.6B NOK 112.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY -5 347 888.9
US
Eli Lilly and Co
NYSE:LLY
747.7B USD 89.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP -15 783.5
DK
Novo Nordisk A/S
CSE:NOVO B
2.8T DKK 29.4
US
Johnson & Johnson
NYSE:JNJ
342.5B USD 23.3
US
Merck & Co Inc
NYSE:MRK
252.8B USD 20.8
CH
Roche Holding AG
SIX:ROG
216.7B CHF 18.8
UK
AstraZeneca PLC
LSE:AZN
170.3B GBP 32.6
CH
Novartis AG
SIX:NOVN
179.3B CHF 11.2
US
Pfizer Inc
NYSE:PFE
152.2B USD 35.8
Earnings Growth PEG
NO
Photocure ASA
OSE:PHO
Average P/E: 41.5
112.3
340%
0.3
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
89.3
76%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29.4
23%
1.3
US
Johnson & Johnson
NYSE:JNJ
23.3
-8%
N/A
US
Merck & Co Inc
NYSE:MRK
20.8
320%
0.1
CH
Roche Holding AG
SIX:ROG
18.8
16%
1.2
UK
AstraZeneca PLC
LSE:AZN
32.6
40%
0.8
CH
Novartis AG
SIX:NOVN
11.2
9%
1.2
US
Pfizer Inc
NYSE:PFE
35.8
102%
0.4

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-312.8
2-Years Forward
P/E
38.6
3-Years Forward
P/E
19.1